Zai Lab partners with Amgen for combination cancer therapy trial
Go back to Zai Lab partners with Amgen for combination cancer therapy trial| Amgen Inc (NASDAQ: AMGN) | Delayed: 415.21 -2.63 (0.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $417.84 | 52 Week High | $176.85 | |||
| Open | $413.76 | 52 Week Low | $133.64 | |||
| Day High | $416.03 | P/E | 62.53 | |||
| Day Low | $410.50 | EPS | $6.64 | |||
| Volume | 2,036,286 | |||||
| (NASDAQ: ZLAB) | Delayed: 25.90 -0.13 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.03 | 52 Week High | $ | |||
| Open | $25.44 | 52 Week Low | $ | |||
| Day High | $26.26 | P/E | N/A | |||
| Day Low | $25.33 | EPS | $ | |||
| Volume | 1,234,060 | |||||
